Trump Warns Of “Retaliation” If India Doesn’t Clear Key Drug Export
Washington/ New Delhi:
India may face retaliation from the United States if it does not release hydroxychloroquine, a key anti-malaria drug used in the treatment of coronavirus, US President Donald Trump said on Monday. His remarks come nearly a week after the government banned export of the drug while experts test its efficacy in helping treat COVID-19 patients.
“I would be surprised if he would, you know, because India does very well with the United States,” Mr Trump told reporters during a press briefing at the White House on Monday.
“So, I would be surprised if that were his (Prime Minister Narendra Modi’s) decision. He’d have to tell me that. I spoke to him Sunday morning, called him, and I said we’d appreciate your allowing our supply to come out. If he doesn’t allow it to come out, that would be okay, but of course there may be retaliation. Why wouldn’t there be?” the US President was quoted as saying by news agency PTI.
